The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.The concept of robots has partially returned, and the Wuzhou New Year, Yuanda Intelligent daily limit, Great Wheel Intelligence, Mingke Jingji, Astar, Fengli Intelligent, Sanfeng Intelligent, etc. have followed suit.Zhengzhou plans to identify three 4A-level scenic spots. On December 12th, it was reported that through the procedures of "voluntary declaration, step-by-step recommendation, landscape review, on-site inspection and party group research", Zhengzhou Municipal Bureau of Culture, Radio, Film and Tourism plans to identify three scenic spots, including Zhongmu Zhengzhou Haichang Ocean Park, Gongyi Qinglong Mountain Ecological Tourism Zone and Guancheng Zhengzhou Shangdu Ancient City Tourist Zone, as national 4A-level tourist attractions. The publicity period is 5 working days from December 9.
The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Shibor reported 1.4820% overnight, down 4.6 basis points; In 7 days, shibor reported 1.6350%, down 8.7 basis points; In three months, shibor reported 1.7400%, down 0.4 basis points.PETER LAMELAS was nominated by Trump as the US ambassador to Argentina.
The negative spread of 10-year national debt between China and the United States has expanded to nearly 250BP, which is the largest in more than 22 years.The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.Actually, Zhijia has set up a new company to sell new energy vehicles. The enterprise search APP shows that recently, Beijing Dongwo Retail Co., Ltd. was established, with the legal representative of Li Jie and the registered capital of 10 million yuan. Its business scope includes: automobile sales; New energy vehicle sales; Wholesale of auto parts; Sales of electrical accessories for new energy vehicles; Sales of power exchange facilities for new energy vehicles. Enterprise investigation shows that the company is indirectly wholly-owned by Juran Zhijia.
Strategy guide 12-13
Strategy guide
Strategy guide
Strategy guide